MedMira, Inc. (CVE:MIR) | Finanzwire

Basculer en Français

9784	Companies
196006	Keywords
127065	Articles
104238	Press releases

Home
Companies
MedMira, Inc.

BRIEF

published on 01/14/2025 at 23:05, 1 year ago

Health Canada Approves MedMira's Rapid HIV Test for Point-of-Care Use

Health Canada MedMira HIV Test Rapid Diagnostics Point-of-Care
PRESS RELEASE

published on 01/14/2025 at 23:00, 1 year ago

MedMira Receives Health Canada Approval for Its Reveal(R) G4 Rapid HIV-1/2 Test for Point-of-Care Use
MedMira Inc. receives Health Canada approval for Reveal® Rapid G4 HIV-1/2 Test for POC use. Achieves 99.64% sensitivity & 99.71% specificity. Test offers immediate results for HIV detection

MedMira Inc. Health Canada Approval Reveal® Rapid G4 HIV-1/2 Test POC Use HIV Detection
BRIEF

published on 01/10/2025 at 00:05, 1 year ago

MedMira Secures Authorization for Syphilis Test Trials

Clinical Trials Health Canada MedMira Syphilis Test REACH Nexus
PRESS RELEASE

published on 01/10/2025 at 00:00, 1 year ago

MedMira Receives Investigational Testing Authorization for its Multiplo(R) Complete Syphilis (TP/nTP) Antibody Test
MedMira Inc. receives Health Canada authorization for clinical trials of Multiplo® Complete Syphilis Antibody Test. Innovative solution for active and past syphilis cases

Clinical Trials MedMira Inc. Health Canada Syphilis Diagnostic Tool
BRIEF

published on 12/31/2024 at 04:05, 1 year 1 month ago

MedMira Reports First Quarter 2025 Results

Financial Results Clinical Trials Regulatory Approval MedMira Q1 FY2025
PRESS RELEASE

published on 12/31/2024 at 04:00, 1 year 1 month ago

MedMira Reports First Quarter Results FY2025
MedMira Inc. reports on financial results for Q1 FY2025, achieving regulatory milestones for HIV and syphilis tests, anticipating revenue growth. Company expands product portfolio and clinical trials progress in the US

Financial Results Clinical Trials MedMira Inc. HIV Test Syphilis Test
BRIEF

published on 12/24/2024 at 18:05, 1 year 1 month ago

MedMira Gains Health Canada Approval for Multiplo® Rapid TP/HIV Test

Health Canada Approval Healthcare Accessibility Multiplo® TP/HIV Rapid Diagnostics HIV And Syphilis
PRESS RELEASE

published on 12/24/2024 at 18:00, 1 year 1 month ago

MedMira receives Health Canada approval for its Multiplo(R) Rapid (TP/HIV) Test for Syphilis and HIV
MedMira Inc. receives Health Canada approval for Multiplo® Rapid TP/HIV Test, addressing HIV and syphilis crises in Canada. Device offers fast, accurate results, ideal for healthcare settings

MedMira Inc. Syphilis HIV Health Canada Approval Multiplo® Rapid TP/HIV Test
BRIEF

published on 11/29/2024 at 05:05, 1 year 2 months ago

MedMira Announces FY2024 Financial Results

FDA Approval Market Strategy MedMira Financial Results HIV Rapid Test Syphilis Testing
PRESS RELEASE

published on 11/29/2024 at 05:00, 1 year 2 months ago

MedMira Reports FY2024 Fourth Quarter and Year End Financial Results
MedMira Inc. reports FY2024 financial results and updates on FDA approval for the Reveal® G4 Rapid HIV-1/2 antibody test, Syphilis clinical trials, and US distribution agreements

Financial Results FDA Approval MedMira Inc. Syphilis Clinical Trials US Distribution Agreements

Accesswire

Published on 02/02/2026 at 23:55, 3 hours 28 minutes ago

2026 Tunkillia Development Drilling Programs Begin
Published on 02/02/2026 at 23:55, 3 hours 28 minutes ago

55 North Mining Announces Winter Exploration Drill Program at Last Hope Gold Project
Published on 02/02/2026 at 23:25, 3 hours 58 minutes ago

Western Announces Sale of GlassMasters Investment
Published on 02/02/2026 at 22:05, 5 hours 18 minutes ago

Organto Foods to Attend Fruit Logistica 2026 in Berlin, Germany From February 4-6, 2026
Published on 02/02/2026 at 15:00, 12 hours 23 minutes ago

Jericho Energy Ventures Strategically Terminates SmartKem LOI to Advance Independent Data Center Energy Infrastructure Platform

View all ACCESSWIRE

EQS Group

Published on 02/02/2026 at 20:00, 7 hours 22 minutes ago

CGTN AMERICA & CCTV UN: Cultural Event Celebrating the Spring Festival and the 55th Anniversary of China-U.S. Ping-Pong Diplomacy
Published on 02/02/2026 at 19:57, 7 hours 25 minutes ago

US federal court grants preliminary injunction allowing Sunrise Wind construction to resume
Published on 02/02/2026 at 19:42, 7 hours 40 minutes ago

EQS-Adhoc: ProSiebenSat.1 publishes preliminary figures for financial year 2025
Published on 02/02/2026 at 19:05, 8 hours 17 minutes ago

Virtual Science AI launches the life science industry's first medical congress AI solution for real-time event conversational intelligence
Published on 02/02/2026 at 18:59, 8 hours 23 minutes ago

EQS-Adhoc: Deutsche Rohstoff AG: Oil and Gas Reserves increase by 46% – NPV of USD 542 million at USD 60 WTI oil price

Les Echos

Published on 02/02/2026 at 18:23, 8 hours 59 minutes ago

Monthly disclosure of the total number of shares and voting rights - January 2026
Published on 02/02/2026 at 18:00, 9 hours 23 minutes ago

Covivio - Information on total number of voting rights and share capital
Published on 02/02/2026 at 17:35, 9 hours 48 minutes ago

Disclosure of transactions in own shares from January 26 to January 30, 2026
Published on 02/02/2026 at 17:22, 10 hours 1 minute ago

Statement of transactions in own shares from January 26, 2026 to January 30, 2026
Published on 02/02/2026 at 08:45, 18 hours 38 minutes ago

BAIKOWSKI: Business growth in 2025

View all LES ECHOS COMFI WIRE